TY - JOUR
T1 - Association between body mass index and results of cryoballoon ablation in Korean patients with atrial fibrillation
T2 - an analysis from the Korean Heart Rhythm Society Cryoablation registry
AU - Ahn, Hyun Jin
AU - Oh, Il Young
AU - Choi, Jung Min
AU - Lee, Kyung Yeon
AU - Ahn, Hyo Jeong
AU - Kwon, Soonil
AU - Choi, Eue Keun
AU - Oh, Seil
AU - Kim, Ju Youn
AU - Cha, Myung Jin
AU - Kwon, Chang Hee
AU - Lee, Sung Ho
AU - Park, Junbeom
AU - Kim, Ki Hun
AU - Yang, Pil Sung
AU - Kim, Jun Hyung
AU - Shim, Jaemin
AU - Lim, Hong Euy
AU - Lee, So Ryoung
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Aims Pulmonary vein isolation using cryoablation is effective and safe in patients with atrial fibrillation (AF). Although both obesity and underweight are associated with a higher risk for incident AF, there is limited data on the efficacy and safety following cryoablation according to body mass index (BMI) especially in Asians. Methods and results Using the Korean Heart Rhythm Society Cryoablation registry, a multicentre registry of 12 tertiary hospitals, we analysed AF recurrence and procedure-related complications after cryoablation by BMI (kg/m2) groups (BMI < 18.5, underweight, UW; 18.5-23, normal, NW; 23-25, overweight, OW; 25-30, obese , O; =30, obese , O ). A total of 2648 patients were included (median age 62.0 years; 76.7% men; 55.6% non-paroxysmal AF). Patients were categorized by BMI groups: 0.9% UW, 18.7% NW, 24.8% OW, 46.1% OI, and 9.4% OII. Underweight patients were the oldest and had least percentage of non-paroxysmal AF (33.3%). During a median follow-up of 1.7 years, atrial arrhythmia recurred in 874 (33.0%) patients (incidence rate, 18.9 per 100 person-years). After multivariable adjustment, the risk of AF recurrence was higher in UW group compared with NW group (adjusted hazard ratio, 95% confidence interval; 2.55, 1.18-5.50, P = 0.02). Procedurerelated complications occurred in 123 (4.7%) patients, and the risk was higher for UW patients (odds ratio, 95% confidence interval; 2.90, 0.94-8.99, P = 0.07), mainly due to transient phrenic nerve palsy.Conclusion Underweight patients showed a higher risk of AF recurrence after cryoablation compared with NW patients.
AB - Aims Pulmonary vein isolation using cryoablation is effective and safe in patients with atrial fibrillation (AF). Although both obesity and underweight are associated with a higher risk for incident AF, there is limited data on the efficacy and safety following cryoablation according to body mass index (BMI) especially in Asians. Methods and results Using the Korean Heart Rhythm Society Cryoablation registry, a multicentre registry of 12 tertiary hospitals, we analysed AF recurrence and procedure-related complications after cryoablation by BMI (kg/m2) groups (BMI < 18.5, underweight, UW; 18.5-23, normal, NW; 23-25, overweight, OW; 25-30, obese , O; =30, obese , O ). A total of 2648 patients were included (median age 62.0 years; 76.7% men; 55.6% non-paroxysmal AF). Patients were categorized by BMI groups: 0.9% UW, 18.7% NW, 24.8% OW, 46.1% OI, and 9.4% OII. Underweight patients were the oldest and had least percentage of non-paroxysmal AF (33.3%). During a median follow-up of 1.7 years, atrial arrhythmia recurred in 874 (33.0%) patients (incidence rate, 18.9 per 100 person-years). After multivariable adjustment, the risk of AF recurrence was higher in UW group compared with NW group (adjusted hazard ratio, 95% confidence interval; 2.55, 1.18-5.50, P = 0.02). Procedurerelated complications occurred in 123 (4.7%) patients, and the risk was higher for UW patients (odds ratio, 95% confidence interval; 2.90, 0.94-8.99, P = 0.07), mainly due to transient phrenic nerve palsy.Conclusion Underweight patients showed a higher risk of AF recurrence after cryoablation compared with NW patients.
KW - Atrial fibrillation
KW - Body mass index
KW - Cryoablation
KW - Underweight
UR - http://www.scopus.com/inward/record.url?scp=85192683515&partnerID=8YFLogxK
U2 - 10.1093/europace/euae095
DO - 10.1093/europace/euae095
M3 - Article
C2 - 38624037
AN - SCOPUS:85192683515
SN - 1099-5129
VL - 26
JO - Europace
JF - Europace
IS - 5
M1 - euae095
ER -